Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ALDH1A2
REST API REST API
Homo sapiens
ALDH1A2 is differentially expressed in 287 experiments: 157 organism parts: testis, bone marrow, ... (155 more);, 202 disease states: normal, acute promyelocytic leukemia, ... (200 more);, 96 cell types 230 cell lines 28 compound treatments and 81 other conditions.
Synonyms RALDH2
Orthologs aldh1a2 (Danio rerio)   Aldh1a2 (Rattus norvegicus)   ALDH1A2 (Bos taurus)   ALD5 (Saccharomyces cerevisiae)   ALDH1A2 (Gallus gallus)   Aldh1a2 (Mus musculus)   ALD4 (Saccharomyces cerevisiae)   ALD6 (Saccharomyces cerevisiae)   ENSCING00000007939 (Ciona intestinalis)   aldh1a2 (Xenopus laevis)   ALDH1A2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term neuron differentiation, cytosol, oxidoreductase activity, cytoplasm, negative regulation of cell proliferation, embryonic digestive tract development, positive regulation of cell proliferation, positive regulation of gene expression, oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor, heart morphogenesis, metabolic process, proximal/distal pattern formation, positive regulation of apoptosis, midgut development, nucleus, morphogenesis of embryonic epithelium, face development, cellular response to retinoic acid, response to cytokine stimulus, pituitary gland development, retinoic acid metabolic process, response to vitamin A, kidney development, 3-chloroallyl aldehyde dehydrogenase activity, hindbrain development, retinal metabolic process, regulation of endothelial cell proliferation, forebrain development, retinal binding, neural crest cell development, embryonic forelimb morphogenesis, retinal dehydrogenase activity, pancreas development, vitamin A metabolic process, blood vessel development, neural tube development, response to estradiol stimulus, lung development, camera-type eye development, 9-cis-retinoic acid biosynthetic process, liver development, determination of bilateral symmetry, embryonic limb morphogenesis, embryonic camera-type eye development, retinoic acid receptor signaling pathway, oxidation-reduction process, anterior/posterior pattern specification
InterPro Term Aldehyde_DH_dom
UniProt Accession Q9UED3, O94788, E9PF31, F5H3R1, F5H2Y9
Search EB-eye ENSG00000128918
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, E-GEOD-8167, ... (29 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-MEXP-1006, E-GEOD-19639, E-GEOD-19397, E-GEOD-2450, E-GEOD-4717, ... (33 experiments)

Factor Value U/D Experiments
HL-60
3
E-GEOD-96, E-GEOD-24147, E-MTAB-37
Jurkat
3
E-MEXP-2197, E-MTAB-62, E-GEOD-1880
K562
3
E-MTAB-37, E-GEOD-96, E-GEOD-24147
U87
2
E-MEXP-903, E-GEOD-20089
MOLT4
2
E-MTAB-37, E-MTAB-62
Raji
2
E-GEOD-96, E-MTAB-37
224 more value(s).


Cell type

studied in E-GEOD-492, E-GEOD-20193, E-GEOD-21668, E-GEOD-3920, E-GEOD-20677, ... (56 experiments)

Factor Value U/D Experiments
endothelial cell
1
3
E-GEOD-3920, E-GEOD-19240, E-GEOD-96, E-GEOD-3998
neutrophil
2
E-GEOD-12662, E-GEOD-995
epithelial cell
1
2
E-MEXP-2034, E-MEXP-1327, E-GEOD-10797
CD4+ T cell
1
2
E-GEOD-16190, E-MEXP-1600, E-MTAB-24
multipotent adult progenitor cell
1
E-MEXP-466
germ cell
1
E-MTAB-25
90 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1577, E-MTAB-62, E-GEOD-5418, ... (61 experiments)

Factor Value U/D Experiments
prostate carcinoma
4
E-GEOD-96, E-MEXP-2034, E-MTAB-62, E-GEOD-7307
benign prostatic hyperplasia
3
E-MEXP-2034, E-GEOD-5377, E-MEXP-1243
chronic myelogenous leukemia
3
E-GEOD-96, E-MTAB-37, E-GEOD-5550
acute promyelocytic leukemia
1
3
E-GEOD-96, E-MTAB-62, E-GEOD-995, E-GEOD-1729
chronic myelogenous leukemia K562
2
E-AFMX-5, E-TABM-145
colon carcinoma
2
E-MTAB-62, E-GEOD-3726
196 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-5258, E-GEOD-3720, E-GEOD-5824, E-GEOD-15811, ... (18 experiments)

Factor Value U/D Experiments
actinomycin D
1
E-GEOD-6400
vanadium pentoxide
1
E-GEOD-5339
5-aza-2'-deoxycytidine + trichostatin A
2
1
E-MEXP-1269
granulocyte-macrophage colony-stimulating factor
1
E-MEXP-2000
phorbol 12-myristate 13-acetate + ionomycin
1
E-GEOD-3720
lipopolysaccharide
1
E-GEOD-3720
22 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, ... (9 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-5999, E-MEXP-2359, E-GEOD-2666, E-GEOD-4667, ... (7 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-1323, E-GEOD-19743, E-GEOD-3325, E-GEOD-2509, E-GEOD-22148, ... (8 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-2299

Genotype
studied in E-GEOD-3494, E-GEOD-17476, E-GEOD-21750, E-MEXP-421, E-TABM-321, ... (10 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-GEOD-7011, E-MEXP-2657, E-GEOD-20540, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-2069, E-TABM-15, E-GEOD-10433, ... (36 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-MEXP-561, E-GEOD-980

Injury
studied in E-GEOD-19743

Irradiate
studied in E-MEXP-2177

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-MEXP-958, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-21750, E-GEOD-1460

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Progression free survival of days
studied in E-GEOD-5851

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Qrt pcr areg dct
studied in E-GEOD-5851

Qrt pcr ereg dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797, E-GEOD-18791

RNAi
studied in E-MEXP-1422, E-MEXP-1509, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, ... (7 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-4883, E-GEOD-20114

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-GEOD-21909, E-GEOD-19246, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 00 005
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271, E-GEOD-1561, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.366 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM